About Glickman Urological & Kidney Institute

Call Us Toll Free:

800.223.2273

Toll-Free: 866.320.4573

Cleveland Clinic's Glickman Urological and Kidney Institute is recognized worldwide for excellence in patient care, teaching and research.

The Glickman Urological and Kidney Institute merges Cleveland Clinic’s urology and nephrology programs. This consolidation of disciplines allows us to better serve patients in the prevention, diagnosis and treatment of kidney disease while we continue to provide high-quality patient care and carry on innovative research in all aspects of urology.

Urology and nephrology physicians and scientists at Cleveland Clinic are recognized worldwide for excellence in patient care, teaching and research. This year, U.S. News & World Report ranked our urology program No. 1 and our nephrology program No. 2 in the nation.

In addition to Cleveland Clinic’s main campus, our urologists and nephrologists practice in the community at Cleveland Clinic family health and surgery centers and in our affiliated medical offices. Whether your doctor refers you or you make your own appointment, you can feel comfortable knowing that the Cleveland Clinic doctor who will care for you is experienced in diagnosing and treating many patients with your condition.

The Institute Advantage

The creation of the Glickman Urological and Kidney Institute reflects the groundbreaking structural changes happening at Cleveland Clinic. In an innovative step toward improved patient care, Cleveland Clinic restructured clinical areas around organ and disease systems, rather than individual specialties. This model is unique in U.S. medicine and is the future of healthcare. By aligning physicians with shared expertise in common institutes, we can offer patients the best in clinical care, research, treatment and prevention.

Eric Klein, MD

Institute Chairman

Robert Heyka, MD

Interim Chairman, Department of Nephrology and Hypertension

Edmund Sabanegh, MD

Chairman, Department of Urology


Center Directors

Nephrology

George Thomas, MD

Center for the Study of Blood Pressure & Fluid Electrolyte Disorders

Martin Lascano, MD

Center for Dialysis

Joseph Nally, MD

Center for Chronic Kidney Disease

Jonathan Taliercio, MD

Center for Renal Diseases

Emilio Poggio, MD

Center for Renal and Pancreas Transplantation


Urology

Manoj Monga, MD

Center for Endourology and Stone Disease

Sandip Vasavada, MD

Center for Female Pelvic Medicine & Reconstructive Surgery

Drogo Montague, MD

Center for Genitourinary Reconstruction

Edmund Sabanegh, MD

Center for Male Fertility

Charles Modlin, MD

Minority Men’s Health Center

Audrey Rhee, MD

Center for Pediatric Urology

David Goldfarb, MD

Center for Renal and Pancreas Transplantation

Ashok Agarwal, PhD

Center for Reproductive Medicine

Jihad Kaouk, MD

Center for Robotic & Laparoscopic Surgery

Andrew Stephenson, MD

Center for Urologic Oncology

Outcomes Book

Download the comprehensive overview of outcomes from the Glickman Urological & Kidney Institute. This book includes 2013 data on clinical outcomes, patient volumes, innovations and publications.

Cleveland Clinic urologist shows that Botox can be used to treat overactive bladders»

Cleveland Clinic urologist, Raymond Rackley, MD, has been using Botox to greatly help patients who suffer from overactive bladder.

Father's Day possible for Rocky River family thanks to vasectomy reversal»

A local family celebrates Father’s Day thanks to a vasectomy reversal by Dr. Edmund Sabanegh.

'Low-T' testosterone ads leading to increase in prescriptions, experts warn»

Researchers sounded an alarm today on ads touting the wonders of testosterone treatments.

Agent Orange and prostate cancer link»

Veterans exposed to Agent Orange have an increased risk of aggressive prostate cancer, analysis finds.

New prostate cancer test first studied at Cleveland Clinic helps predict cancer risk»

"This is really a boon for patients," said urologist Dr. Eric Klein, chairman of the Glickman Urological and Kidney Institute at the Clinic who oversaw the research. Klein said he hopes the new test will address the reluctance that many patients have when given the option to "watch and wait," and the reluctance many physicians have of offering that option.

Gene test may help guide prostate cancer treatment»

"Unless you can be sure your biopsy has hit the most aggressive part that's in the prostate, you can't be sure" how accurate your risk estimate is, explained Dr. Eric Klein, chief of urology at Cleveland Clinic, who led early development of the Oncotype prostate cancer test.

Call us for an Appointment

Urology Appointments: 800.223.2273 ext. 4-5600
Nephrology Appointments: 800.223.2273 ext. 4-6771

This information is provided by Cleveland Clinic and is not intended to replace the medical advice of your doctor or health care provider. Please consult your health care provider for advice about a specific medical condition.

© Copyright 2014 Cleveland Clinic. All rights reserved.

Cleveland Clinic Mobile Site